Cargando…
Emerging Biomarkers and the Changing Landscape of Small Cell Lung Cancer
SIMPLE SUMMARY: Small cell lung cancer (SCLC) is an aggressive cancer representing 15% of all lung cancers. Unlike other types of lung cancer, treatments for SCLC have changed very little in the past 20 years and therefore, the survival rate remains low. This is due, in part, to the lack of understa...
Autores principales: | Keogh, Anna, Finn, Stephen, Radonic, Teodora |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367597/ https://www.ncbi.nlm.nih.gov/pubmed/35954436 http://dx.doi.org/10.3390/cancers14153772 |
Ejemplares similares
-
Treatment Strategies for KRAS-Mutated Non-Small-Cell Lung Cancer
por: O’Sullivan, Éabha, et al.
Publicado: (2023) -
Origins, genetic landscape, and emerging therapies of small cell lung cancer
por: Semenova, Ekaterina A., et al.
Publicado: (2015) -
The Emerging Therapeutic Landscape of ALK Inhibitors in Non-Small Cell Lung Cancer
por: Gristina, Valerio, et al.
Publicado: (2020) -
Recent progress in mapping the emerging landscape of the small-cell lung cancer genome
por: Kim, Kee-Beom, et al.
Publicado: (2019) -
The emerging treatment landscape of targeted therapy in non-small-cell lung cancer
por: Yuan, Min, et al.
Publicado: (2019)